共 50 条
- [21] Structural characterization of monastrol and Eg5 kinesin interactions: A difference infrared investigation[J]. BIOPHYSICAL JOURNAL, 2004, 86 (01) : 408A - 408AWojcik, EJDalrymple, NAWalker, RBevan, DCrosby, KKim, S
- [22] Discovery, synthesis and characterization of hexahydropyranoquinolines as a novel class of selective inhibitors of the mitotic kinesin Eg5.[J]. CANCER RESEARCH, 2006, 66 (08)Finsinger, DirkZenke, Frank T.Amendt, ChristianeSchiemann, KaiEmde, UlrichKnoechel, ThorstenBomke, JoergGleitz, JohannesWilm, ClaudiaMeyring, MichaelOsswald, MathiasFunk, Jens-Oliver
- [23] Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway[J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 175Alburquerque-Gonzalez, BegonaMontoro-Garcia, SilviaBernabe-Garcia, AngelBernabe-Garcia, ManuelCampioni-Rodrigues, PriscilaRodriguez-Martinez, AlejandroLuque, IreneSalo, TuulaPerez-Garrido, AlfonsoPerez-Sanchez, HoracioCayuela, Maria LuisaLuengo-Gil, GinesLuchinat, EnricoPostigo-Corrales, FatimaStaderini, TommasoNicolas, Francisco JoseConesa-Zamora, Pablo
- [24] Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint[J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (10) : 2580 - 2591Chin, Gregory M.Herbst, Ronald
- [25] Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5[J]. JOURNAL OF CELL BIOLOGY, 2000, 150 (05): : 975 - 988Kapoor, TMMayer, TUCoughlin, MLMitchison, TJ
- [26] Probing the spindle assembly checkpoint with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5[J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 97A - 97AKapoor, TMMayer, TUCoughlin, MLMitchison, TJ
- [27] The Motility of Monomeric and Dimeric Variants of Eg5 studied in the Presence of the Kinesin-5-specific Inhibitor Monastrol[J]. BIOPHYSICAL JOURNAL, 2009, 96 (03) : 571A - 571ALakamper, StefanThiede, ChristinaReiter, Stefanievon Roden, KerstinSchmidt, Christoph F.
- [28] Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity[J]. ARCHIV DER PHARMAZIE, 2022, 355 (10)Thabit, Mohamed G.Mostafa, Amany S.Selim, Khalid B.Elsayed, Magda A. A.Nasr, Magda N. A.
- [29] Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines[J]. BIOCHEMICAL PHARMACOLOGY, 2010, 79 (06) : 864 - 872Tcherniuk, Sergeyvan Lis, RobertKozielski, FrankSkoufias, Dimitrios A.
- [30] Cytotoxic monastrol derivatives as adjective inhibitors of drug-resistant Eg5: a molecular dynamics perspective[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,Shahabipour, S.Shamkhali, A. N.Razzaghi-Asl, N.